CellCentric's Grant

CellCentric raised a round of funding on May 15, 2006.

CellCentric is a clinical stage biotechnology company focused on the development of the novel drug CCS1477 for prostate (CRPC) and other cancers.…

Articles about CellCentric's Grant: